Prof. Davide Brambilla
Davide graduated in Biotechnology at the University of Milano-Bicocca, Italy, in 2008. After completion of a Master in Medical Biotechnology, he performed his PhD at the School of Pharmacy at the University of Paris under the supervision of Prof. Patrick Couvreur focused on the design of polymeric nanoparticles for diverse biomedical applications. In 2012, he moved to the Department of Chemistry and Applied Biosciences at the Swiss Federal Institute of Technology (ETH) Zurich in the group of JC Leroux, where, after 3 years of post-doctoral stay, he was promoted group leader in 2015. In 2017, he has been appointed Assistant Professor at the School of Pharmacy at the Université de Montréal, where he started his independent research laboratory at the interface of biotechnology and pharmaceutical sciences. He teaches the Drug Delivery, Development of Biotechnology Drugs and Pharmacokinetics. His research interest include the design of polymeric microneedles for the non-invasive transdermal delivery of on-purpose designed diagnostic and therapeutic agents as well as new nanoparticulate and bio-conjugates platforms for the targeted delivery of biotherapeutic agents. He is member of the Controlled Release Society, the Canadian Biomaterial Society, the Canadian Society of Pharmaceutical Sciences and current secretary of the Canada Chapter of the Controlled Release Society.
He holds the Research Chaire in Biotherapy from the Canadian Generic Pharmaceutical Association and Biosimilars Canada
Dr. Mahdi Roohnikan
Mahdi completed his BSc and MSc in Polymer engineering at Amirkabir university of technology (Tehran Polytechnic) in 2009 and 2012, respectively. During his Master’s he developed a liquid crystal based optically active molecule with macromolecular properties. He then got admitted to McGill University in Chemical engineering to pursue his PhD under the supervision of Prof. Linda Reven (Chemistry Department) and Prof. Alejandro Rey. His thesis concerned developing stable Hydrogen-bonding liquid crystal nanocomposites based on fluorescent and plasmonic nanoparticles, he has finished his degree this summer. His research interests range from materials science and nanotechnology to drug-delivery and diagnostics. He has recently joined Prof. Brambilla’s group at Université de Montréal as a postdoctoral researcher to work on new non-invasive diagnosis methods in collaboration with the laboratory of Profs. Banquy (UdeM), DeCrescenzo (Polytechnique) and the Montreal Heart Institute.
Philippe completed his BSc and MSc in pharmaceutical sciences from the university of Geneva (2016) and Basel (2018), respectively. He worked on his Master thesis at the University of Lausanne Ludwig Cancer Research center, where he characterized the CD8 T-cell response in the presence of mutants of an immunodominant antigenic peptide. During this work he used the yellow fever vaccine YF-17D as a model for immunity. After graduating from his Master's degree, he worked as a research assistant at the department of microbiology and molecular medecine of the university of Geneva, under the supervision of Professor Dominique Soldati-Favre, with a focus on parasitology and the Apicomplexan parasite Toxoplasma Gondii. He joined our team as a PhD student in the summer of 2019 to work on novel approaches for the treatment of neuro-degenerative diseases.
Sam graduated with a degree in Biochemistry from Concordia University in 2016. During that time, he completed a summer internship with Dr. Sultan Darvesh at Dalhousie University in Halifax, Nova Scotia and worked on his Honours thesis project in Dr. Pat Forgione’s lab. In 2019 he completed a MSc degree in Pharmaceutical Science in the laboratory of Prof. Brambilla. His research interests include the development of bioinspired drugs and drug delivery systems. He is currently performing his PhD on the design of fluorescent probes for biological analytes and optimizing their delivery to the skin using microneedles.